A general strategy to optimize immunogenicity of HLA-B*0702 restricted cryptic peptides from tumor associated antigens: Design of universal neo-antigen like tumor vaccines for HLA-...

por Gallou, Catherine, Rougeot, Aude, Graff-Dubois, Stéphanie, Kosmatopoulos, Kostas, Menez-Jamet, Jeanne
Publicado 2016

Clinical Activity of an hTERT-Specific Cancer Vaccine (Vx-001) in “Immune Desert” NSCLC

por Pateras, Ioannis S., Kotsakis, Athanasios, Avgeris, Margaritis, Baliou, Evangelia, Kouroupakis, Panagiotis, Patsea, Eleni, Georgoulias, Vassilis, Menez-Jamet, Jeanne, Kinet, Jean-Pierre, Kosmatopoulos, Kostas
Publicado 2021

Clinical activity of a htert (vx-001) cancer vaccine as post-chemotherapy maintenance immunotherapy in patients with stage IV non-small cell lung cancer: final results of a randomi...

por Gridelli, Cesare, Ciuleanu, Tudor, Domine, Manuel, Szczesna, Aleksandra, Bover, Isabel, Cobo, Manuel, Kentepozidis, Nikolaos, Zarogoulidis, Konstantinos, Kalofonos, Charalabos, Kazarnowisz, Andrzej, Korozan, Magdalena, de las Penas, Ramon, Majem, Margarita, Chella, Antonio, Griesinger, Frank, Bournakis, Evangelos, Sadjadian, Parvis, Kotsakis, Athanasios, Chinet, Thierry, Syrigos, Kostantinos N., Correale, Pierpaolo, Gallou, Catherine, Jamet, Jeanne- Menez, Vetsika, Eleni- Kyriaki, Kosmatopoulos, Kostas, Georgoulias, Vassilis
Publicado 2020